Pandemic Incident Management for Vaccine Safety Challenges: Victoria's Alert Advisory Group Experience.


Journal

Disaster medicine and public health preparedness
ISSN: 1938-744X
Titre abrégé: Disaster Med Public Health Prep
Pays: United States
ID NLM: 101297401

Informations de publication

Date de publication:
03 Sep 2024
Historique:
medline: 18 9 2024
pubmed: 3 9 2024
entrez: 3 9 2024
Statut: epublish

Résumé

Safe vaccines are critical for biosecurity protection, yet adverse events-rightly or wrongly attributed to immunization-potentially cause rapid loss of confidence, reduced vaccine uptake, and resurgence of preventable disease. Effective vaccine safety incident management is essential to provide assessment and lead appropriate actions to ensure vaccination programs are safe and mitigate unwarranted crisis escalation that could damage vaccine programs and the effective control of vaccine preventable disease outbreaks or pandemics. Incident management systems (IMS) are used globally to direct emergency management response, particularly for natural disasters of fire, flood, and storm. Public health is equally an emergency response and can therefore benefit from these command control constructs. While examples of IMS for outbreak response and mass immunization logistics exist, there is little to no information on their use in vaccine safety. We describe Australia's vaccine safety Alert Advisory Group establishment in Victoria during the COVID-19 pandemic and onward embedding into routine practice, anticipant of new vaccines, and the next biosecurity threat.

Identifiants

pubmed: 39225231
doi: 10.1017/dmp.2024.100
pii: S1935789324001009
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e137

Auteurs

Hazel J Clothier (HJ)

Epi-Informatics, Centre for Health Analytics, Melbourne Children's Campus, Victoria, Australia.
Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC), Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
COVID-19 Response, Department of Health Victoria, Melbourne, Australia.
Department of Pediatrics, The University of Melbourne, Melbourne, Victoria, Australia.

Michelle Wolthuizen (M)

COVID-19 Response, Department of Health Victoria, Melbourne, Australia.

Ingrid Laemmle-Ruff (I)

Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC), Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Georgina Lewis (G)

Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC), Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Catherine Radkowski (C)

Immunisation Unit, Department of Health Victoria, Melbourne, Australia.

Jim Buttery (J)

Epi-Informatics, Centre for Health Analytics, Melbourne Children's Campus, Victoria, Australia.
Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC), Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
COVID-19 Response, Department of Health Victoria, Melbourne, Australia.
Department of Pediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
Infectious Diseases, Department of General Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.

Nigel Crawford (N)

Surveillance of Adverse Events Following Vaccination in the Community (SAEFVIC), Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
COVID-19 Response, Department of Health Victoria, Melbourne, Australia.
Department of Pediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
Infectious Diseases, Department of General Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH